Treatment of Brain Metastases
rule

Combination of Targeted Therapies and SRS
for the Treatment of Brain Metastases


A session from the Radiosurgery Society 2017 Webinar Series presented by:

  • Samuel Chao, MD, Cleveland Clinic, Brain Tumor and Neuro-Oncology Center and the Department of Radiation Oncology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Jonathan Sherman, MD, Director of Surgical Neuro-oncology, and Director of Stereotactic Radiosurgery at The George Washington University School of Medicine & Health Sciences, Washington, DC

This course, which has been accredited by the American Board of Radiology (ABR) for both physicians and medical physicists, is available from August 25, 2017 through 11:59 p.m. Eastern time on August 25, 2020.

In order to earn credit for this course, participants must:

    • View the audio/slide presentation
    • Pass the five-question examination with a minimum of 70 percent, and
    • Complete the course evaluation
The activity is approximately 1-hour in length.

STATEMENT OF NEED

Brain metastasis affects up to 200,000 patients yearly and is the most common neurological complication of cancer. Studies indicate that SRS shows benefits compared to whole brain radiation treatment (WBRT) for patients with brain metastases by reducing damage to normal tissues, decreasing treatment time and reducing neurocognitive decline. There is a need to review the current state of the literature on SRS alone vs. WBRT with SRS boost vs. SRS plus targeted therapies, to understand the benefits and risks of each in the pre vs post-operative setting, and discuss future studies needed to maximize the therapeutic benefits of SRS for the treatment of brain metastases.


TARGET AUDIENCE

This program is designed to meet the needs of radiation oncologists, neurosurgeons, medical physicists, residents-in-training and healthcare professionals with interest in learning about defining progression versus pseudoprogression, targeted agents, WBRT, and optimizing Radiosurgery (SRS) to treat brain metastases.


ACTIVITY OBJECTIVES

  • Defining progression versus pseudoprogression following stereotactic radiosurgery
  • Defining the role WBRT versus stereotactic radiosurgery after distal progression
  • Review the role of stereotactic radiosurgery (SRS) for brain metastases
  • Discuss ways to optimize radiosurgery in brain
  • Provide an overview on the use of targeted agents in treating brain metastases


ACCREDITATION STATEMENT

In order to successfully complete this knowledge-based continuing education activity, the participant must register for the activity, view the educational sessions, and complete the online examination and activity evaluation.


CONTINUING MEDICAL EDUCATION (CME)

The Radiosurgery Society Self-Assessment Module (SAM) titled Combination of Targeted Therapies and SRS for the Treatment of Brain Metastases is qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has been qualified for 1.0 SAM credits. The ABR qualified this SAM on August 25, 2017.


CONTINUING EDUCATION (CE)

The Radiosurgery Society Self-Assessment Module (SAM) titled Combination of Targeted Therapies and SRS for the Treatment of Brain Metastases is qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has been qualified for 1.0 SAM credits. The ABR qualified this MP SAM on August 25, 2017.


CERTIFICATION OF PARTICIPATION

A certificate will be issued upon completion of course requirements, including the evaluation, enabling you to register your credit with the appropriate licensing boards or associations.


COURSE FEES

  • Non-Member: $25.00
  • RSS Member: Free
    • Once logged in to www.therss.org, members can find the discount code on the Member Resources page.

TECHNOLOGY REQUIREMENTS

Software Requirements

  • A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher

A note on browser incompatibility:

  • We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
  • Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
  • Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot. http://get.adobe.com/flashplayer/

Hardware Requirements

  • Windows Based Computer, Mac based Computers, smart phone, tablets
  • Windows XP SP 3 or Vista Home Premium or better
  • Mac OS x 10.5.3 or better
  • Pentium 4 or better
  • 1meg of System Ram (Memory)
  • True Color 32 bit video card
  • Soundcard and speakers
For more help with technical issues please click here.

POLICIES

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.

Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.

Please contact admin@therss.org if you have questions.

Member login  
rule
   

   
Our thoughts and prayers are with the victims, their loved ones, and all those that had to bear witness to such tragedy.

   

the RSS would like to
acknowledge and thank our 
Corporate Sponsors.



the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice
Sponsors.







  
the RSS is pleased to collaborate with the following:







Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype
divider